Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adma, Aprea, Astellas, Celltrion, Delta-Fly, Formycon, Lexicon, Mesoblast, Novo Nordisk, Pfizer, Regeneron, Transthera, Travere, Viatris.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Anheart Therapeutics, Astrazeneca, Formosa, Transthera, Visen.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Bristol Myes Squibb, Eli Lilly, Transthera, Visen.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cepheid, Pulsecath.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Creative Medical Technology, Fresenius Kabi, Ionctura, Mind Medicine.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Calliditas, Creative Medical, Daiichi, Iecure, Janssen, Lumicell, NX, Pysence, Sandoz, Vanda, Verastem.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Co-Diagnostics, Cosara, Quidelortho, Surgentec.
RSS